PD-1 and PD-L1 Inhibitors Pipeline Forecast to 2025

3 months ago, Fri, Sep 1, 2017, 12:49:24
Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) inhibitors are the therapeutic candidates or drugs, popularly known as checkpoint inhibitors, used most commonly for the treatment of cancer and other malignancies.

Comments